Gopisankar Mohanannair Geethadevi

Gopisankar Mohanannair Geethadevi is a Research Fellow at Monash University's Centre for Medicine Use and Safety (CEMUSS), affiliated with the Health Economics and Policy Evaluation Research Team (HEPER). Their work focuses on clinical prediction models, health economics, pharmacogenomics, and epilepsy research with contributions to global healthcare policy. Current research emphasizes dementia prevention, cardiovascular risk pathways, and mHealth interventions.

• University: Monash University
• Department: Centre for Medicine Use and Safety

Research interests span dementia risk reduction through multidomain interventions, pharmacoepidemiology, and stress-related cardiovascular mechanisms. Recent studies include protocol development for the HAPPI MIND trial, reviews of cancer surrogate outcomes for policy decisions, and systematic analyses of airway disease treatments.

Publications highlight contributions to Cochrane Reviews, BMJ Open, and the Journal of the American College of Cardiology. Their work aligns with UN Sustainable Development Goals related to good health and well-being.